Daxxify's marketing promise—up to 6 months of effect versus Botox's standard 12 weeks—has reshaped competitive positioning in the toxin space. But the clinical reality is more nuanced than the headline suggests. Real-world efficacy depends on patient metabolism, injection technique, and unit dosing; some patients see meaningful extension, others see minimal difference.
Injectables
Daxxify Duration Claims vs. Reality
What the data actually shows about Revance's longer-lasting neuromodulator.

1-YEAR MOVE
ABBV
▲11.6%
| Ticker | Company | 1-year change |
|---|---|---|
| ABBV | AbbVie (Allergan Aesthetics) | +11.6% |